{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:17:17Z","timestamp":1769084237502,"version":"3.49.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":899,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,5,28]],"date-time":"2023-05-28T00:00:00Z","timestamp":1685232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Avtal om L\u00e4karutbildning och Forskning"},{"name":"Janssen-Cilag AB"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Heart failure (HF) is a frequent condition in the elderly, further complicated by associated pulmonary hypertension (PH), with impact on morbidity and mortality. Plasma proteins associated with cardiovascular disease, related to inflammation, neurohormonal changes, and myocyte stress, pathways recognized in the pathophysiology of HF, may provide information on disease severity and prognosis. We aimed to investigate such cardiovascular proteins and their relationship to haemodynamics before and 1 year after heart transplantation (HT), as well as their prognostic value in advanced HF with PH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In 20 healthy controls and 67 patients with HF and PH, before and 1 year after HT, N-terminal pro-brain natriuretic peptide (NT-proBNP) and 18 cardiovascular proteins were analysed with proximity extension assay. Right heart catheterization was used to measure the haemodynamics of the HF patients pre-operatively and at 1 year follow-up after HT. Prognosis was estimated using Kaplan\u2013Meier and Cox regression analyses. Out of 18 plasma proteins, 11 proteins including adrenomedullin peptides and precursor levels (ADM) and protein suppression of tumourigenicity 2 receptor were elevated before HT compared with healthy controls and had decreased 1 year after HT. The decrease in plasma levels 1 year after HT was towards the healthy controls' levels. The decrease in ADM levels before vs. after HT correlated with decreased mean right atrial pressure (rs = 0.61; P = 0.0077), decreased NT-proBNP (rs = 0.75; P = 0.00025), and decreased stroke volume index (rs = \u22120.52; P = 0.022). High levels of pre-operative plasma ADM were associated with worse event-free survival (HT or death), as well as survival compared with low ADM levels (log-rank P value = 0.023 and 0.0225, respectively). Univariable Cox regression analysis demonstrated that ADM levels were associated with survival, hazard ratio (HR) 1.007 (95% confidence interval (CI): 1.00\u20131.015, P = 0.049), and the association remained after adjusting for NT-proBNP, HR 1.01 (95% CI: 1.00\u20131.021, P = 0.041).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated plasma levels of ADM may be a marker of pressure\/volume overload in HF patients with PH, as well as long-term prognosis after HT. In line with previous studies, our findings additionally confirm that ADM may be a marker of venous congestion in HF. Further studies are encouraged to establish a deeper understanding of the properties of ADM and its relationship with HF and PH, in order to potentially facilitate clinical management of HF and associated PH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14399","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T00:27:09Z","timestamp":1685320029000},"page":"2427-2437","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adrenomedullin Peptides and Precursor Levels in Relation to Haemodynamics and Prognosis After Heart Transplantation"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6005-5300","authenticated-orcid":false,"given":"Abdulla","family":"Ahmed","sequence":"first","affiliation":[{"name":"The Section for Cardiology, Department of Clinical Sciences, Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, VO Heart and Lung Medicine, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2190-1583","authenticated-orcid":false,"given":"Kriss","family":"Kania","sequence":"additional","affiliation":[{"name":"The Section for Cardiology, Department of Clinical Sciences, Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, VO Heart and Lung Medicine, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hebba","family":"Abdul Rahim","sequence":"additional","affiliation":[{"name":"The Section for Cardiology, Department of Clinical Sciences, Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, VO Heart and Lung Medicine, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7086-6262","authenticated-orcid":false,"given":"Salaheldin","family":"Ahmed","sequence":"additional","affiliation":[{"name":"The Section for Cardiology, Department of Clinical Sciences, Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, VO Heart and Lung Medicine, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-2771","authenticated-orcid":false,"given":"G\u00f6ran","family":"R\u00e5degran","sequence":"additional","affiliation":[{"name":"The Section for Cardiology, Department of Clinical Sciences, Lund, Lund University , Lund ,","place":["Sweden"]},{"name":"The Haemodynamic Lab, The Section for Heart Failure and Valvular Disease, VO Heart and Lung Medicine, Sk\u00e5ne University Hospital , Lund ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,5,28]]},"reference":[{"key":"2026012114084727800_ehf214399-bib-0001","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012114084727800_ehf214399-bib-0002","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamainternmed.2015.0924","article-title":"A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010","volume":"175","author":"Gerber","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2026012114084727800_ehf214399-bib-0003","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jchf.2018.03.006","article-title":"Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Tsao","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2026012114084727800_ehf214399-bib-0004","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","article-title":"Epidemiology of heart failure","volume":"113","author":"Roger","year":"2013","journal-title":"Circ Res"},{"key":"2026012114084727800_ehf214399-bib-0005","first-page":"1","article-title":"Heart failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"JACC: Heart Failure"},{"key":"2026012114084727800_ehf214399-bib-0006","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","author":"Humbert","year":"2022","journal-title":"Eur Respir J"},{"key":"2026012114084727800_ehf214399-bib-0007","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012114084727800_ehf214399-bib-0008","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: developed by the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2026012114084727800_ehf214399-bib-0009","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMra0800239","article-title":"Biomarkers in heart failure","volume":"358","author":"Braunwald","year":"2008","journal-title":"N Engl J Med"},{"key":"2026012114084727800_ehf214399-bib-0010","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/CIRCRESAHA.118.312706","article-title":"Established and emerging roles of biomarkers in heart failure","volume":"123","author":"Ibrahim","year":"2018","journal-title":"Circ Res"},{"key":"2026012114084727800_ehf214399-bib-0011","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/j.2040-4603.2014.tb00567.x","article-title":"Classical renin-angiotensin system in kidney physiology","volume":"4","author":"Sparks","year":"2014","journal-title":"Compr Physiol"},{"key":"2026012114084727800_ehf214399-bib-0012","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/eurheartj\/14.suppl_C.14","article-title":"Heart failure, ventricular remodelling and the renin-angiotensin system: insights from recently completed clinical trials","volume":"14","author":"Young","year":"1993","journal-title":"Eur Heart J"},{"key":"2026012114084727800_ehf214399-bib-0013","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012114084727800_ehf214399-bib-0014","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/eurjhf\/hfq031","article-title":"Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure","volume":"12","author":"von Haehling","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026012114084727800_ehf214399-bib-0015","first-page":"e154","article-title":"ACC\/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"2026012114084727800_ehf214399-bib-0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS ONE"},{"key":"2026012114084727800_ehf214399-bib-0017","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"2026012114084727800_ehf214399-bib-0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2026012114084727800_ehf214399-bib-0019","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.healun.2006.06.008","article-title":"Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates\u20142006","volume":"25","author":"Mehra","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"2026012114084727800_ehf214399-bib-0020","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1515\/cclm-2013-0741","article-title":"The revised Lund-Malmo GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population","volume":"52","author":"Nyman","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"2026012114084727800_ehf214399-bib-0021","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"2026012114084727800_ehf214399-bib-0022","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)","volume":"10","author":"Dickstein","year":"2008","journal-title":"Eur J Heart Fail."},{"key":"2026012114084727800_ehf214399-bib-0023","first-page":"223","article-title":"Prolargin and matrix metalloproteinase-2 in heart failure after heart transplantation and their association with haemodynamics","volume":"7","author":"Ahmed","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012114084727800_ehf214399-bib-0024","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/ehf2.12772","article-title":"Elevated plasma sRAGE and IGFBP7 in heart failure decrease after heart transplantation in association with haemodynamics","volume":"7","author":"Ahmed","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012114084727800_ehf214399-bib-0025","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s00380-019-01548-1","article-title":"Elevated plasma tyrosine kinases VEGF-D and HER4 in heart failure patients decrease after heart transplantation in association with improved haemodynamics","volume":"35","author":"Ahmed","year":"2020","journal-title":"Heart Vessels"},{"key":"2026012114084727800_ehf214399-bib-0026","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1007\/s00380-020-01656-3","article-title":"Elevated plasma endocan and BOC in heart failure patients decrease after heart transplantation in association with improved hemodynamics","volume":"35","author":"Ahmed","year":"2020","journal-title":"Heart Vessels"},{"key":"2026012114084727800_ehf214399-bib-0027","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1002\/ehf2.14148","article-title":"Elevated plasma WIF-1 levels are associated with worse prognosis in heart failure with pulmonary hypertension","volume":"n\/a","author":"Kania","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084727800_ehf214399-bib-0028","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0002-8703(98)70333-3","article-title":"Plasma levels of adrenomedullin in patients with mitral stenosis","volume":"135","author":"Yamamoto","year":"1998","journal-title":"Am Heart J"},{"key":"2026012114084727800_ehf214399-bib-0029","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.repce.2016.11.012","article-title":"Mid-regional pro-adrenomedullin and ST2 in heart failure: contributions to diagnosis and prognosis","volume":"36","author":"Lopes","year":"2017","journal-title":"Revista Portuguesa de Cardiologia (English Edition)"},{"key":"2026012114084727800_ehf214399-bib-0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ejhf.1366","article-title":"Adrenomedullin in heart failure: pathophysiology and therapeutic application","volume":"21","author":"Voors","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026012114084727800_ehf214399-bib-0031","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0196-9781(01)00513-7","article-title":"A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides","volume":"22","author":"Eto","year":"2001","journal-title":"Peptides"},{"key":"2026012114084727800_ehf214399-bib-0032","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1002\/ehf2.14018","article-title":"Bioactive adrenomedullin for assessment of venous congestion in heart failure","volume":"n\/a","author":"Egerstedt","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012114084727800_ehf214399-bib-0033","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jacc.2010.02.025","article-title":"Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial","volume":"55","author":"Maisel","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026012114084727800_ehf214399-bib-0034","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jacc.2004.04.059","article-title":"Furosemide and the progression of left ventricular dysfunction in experimental heart failure","volume":"44","author":"McCurley","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026012114084727800_ehf214399-bib-0035","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1006\/jmcc.2000.1129","article-title":"Induction of cardiac fibrosis by aldosterone","volume":"32","author":"Lijnen","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"2026012114084727800_ehf214399-bib-0036","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"2026012114084727800_ehf214399-bib-0037","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ejhf.799","article-title":"Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides","volume":"19","author":"D'Elia","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012114084727800_ehf214399-bib-0038","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/cvr\/cvq331","article-title":"Mechanisms involved in increased plasma brain natriuretic peptide after heart transplantation","volume":"89","author":"Talha","year":"2011","journal-title":"Cardiovasc Res"},{"key":"2026012114084727800_ehf214399-bib-0039","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1399-0012.2008.00818.x","article-title":"Does circulating BNP normalize after heart transplantation in patients with normal hemodynamic and right and left heart functions?","volume":"22","author":"Talha","year":"2008","journal-title":"Clin Transplant"},{"key":"2026012114084727800_ehf214399-bib-0040","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3803\/EnM.2017.32.2.180","article-title":"Glucocorticoid-induced diabetes mellitus: an important but overlooked problem","volume":"32","author":"Suh","year":"2017","journal-title":"Endocrinol Metab (Seoul, Korea)"},{"key":"2026012114084727800_ehf214399-bib-0041","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4239\/wjd.v5.i3.364","article-title":"Adrenomedullin and diabetes","volume":"5","author":"Wong","year":"2014","journal-title":"World J Diabetes"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/4\/2427\/64704854\/eschf_10_4_2427.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/4\/2427\/64704854\/eschf_10_4_2427.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:09:28Z","timestamp":1769022568000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/10\/4\/2427\/8285295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,28]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,5,28]]},"published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14399","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,5,28]]},"assertion":[{"value":"2023-01-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}